Back

DIDO3 acts at the interface of RNAPII transcription and chromatin structure regulation

Pons, T.; Serra, F.; Pazos, F.; Valencia, A.; Martinez-A, C.

2021-09-29 bioinformatics
10.1101/2021.09.27.462041 bioRxiv
Show abstract

Chromatin structure and organization has a key role in gene expression regulation. Here, we integrated ChIP-seq, RNA-seq, Hi-C, epigenetic, and cancer-related mutations data to get insight into the role of Death Inducer Obliterator gene (Dido1) in RNA pol II (RNAPII) transcription and chromatin structure regulation. Analysis of ChIP-seq data of DIDO3, the largest protein isoform of Dido1, revealed binding-sites overlap about 70% with RNAPII and H3K36me3 in the mouse genome, but also significant overlap 10-30% with Polycomb, CTCF, H3K4me3, and H3K27ac. Based on this analysis we propose that DIDO3s PHD domain interacts with H3K36me3 posttranslational modification. Integrating multi-omics data we describe how DIDO3 potentially recruit several transcription factors, including RNAPII, and also regulates genes transcribing those same transcription factors. DIDO3 regulation of the genes traduced into proteins to which it binds puts DIDO3 in the center of intricate feedback loops. We showed, by using data from a DIDO3 mutant, that DIDO3 C-terminus is responsible for most of these transcriptional regulation, and is also implicated in other very important pathways by regulating genes encoding for Polycomb-accessory proteins, subunits of the SWI/SNF chromatin remodelling, or Set1/COMPASS chromatin modifier complexes. These multi-protein complexes control gene activation or silencing and also play a role in tumour development. DIDO3 C-terminus region and splice-site for alternative DIDO2/DIDO3 protein isoforms tended to accumulate recurrent truncating mutations identified in the TCGA Pan-Cancer dataset. We hypothesize that deregulation of DIDO3, as it happens with large epigenetic complexes and long-range interactions, leads to cell differentiation deficiency and cancer development. Overall, we propose here a molecular mechanism by which DIDO3, favour RNAPII pausing and long-range chromatin interactions.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Nucleic Acids Research
1281 papers in training set
Top 0.1%
41.1%
2
Epigenetics & Chromatin
42 papers in training set
Top 0.1%
22.8%
50% of probability mass above
3
BMC Genomics
406 papers in training set
Top 2%
3.6%
4
NAR Genomics and Bioinformatics
242 papers in training set
Top 1%
3.4%
5
Clinical Epigenetics
60 papers in training set
Top 0.3%
1.8%
6
NAR Cancer
37 papers in training set
Top 0.4%
1.5%
7
BMC Biology
265 papers in training set
Top 3%
1.4%
8
International Journal of Molecular Sciences
494 papers in training set
Top 10%
1.2%
9
Cell Cycle
17 papers in training set
Top 0.3%
1.2%
10
Computational and Structural Biotechnology Journal
242 papers in training set
Top 5%
1.1%
11
PLOS Genetics
862 papers in training set
Top 10%
1.1%
12
iScience
1154 papers in training set
Top 29%
1.0%
13
Science Advances
1243 papers in training set
Top 28%
1.0%
14
RNA Biology
78 papers in training set
Top 1%
0.9%
15
Genes
144 papers in training set
Top 4%
0.9%
16
Epigenetics
50 papers in training set
Top 0.6%
0.9%
17
Life Science Alliance
285 papers in training set
Top 7%
0.9%
18
Biomedicines
67 papers in training set
Top 3%
0.6%
19
The FASEB Journal
194 papers in training set
Top 6%
0.6%
20
Genome Biology
637 papers in training set
Top 9%
0.6%
21
Scientific Reports
3612 papers in training set
Top 77%
0.6%
22
Cells
249 papers in training set
Top 8%
0.6%
23
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 6%
0.5%
24
Journal of Molecular Biology
232 papers in training set
Top 5%
0.5%
25
Cellular and Molecular Life Sciences
96 papers in training set
Top 3%
0.5%
26
Frontiers in Immunology
638 papers in training set
Top 11%
0.5%
27
PLOS ONE
5266 papers in training set
Top 67%
0.5%